CapsoVision (NASDAQ:CV) Issues Quarterly Earnings Results

CapsoVision (NASDAQ:CV) announced its earnings results on Thursday. The company reported $0.02 earnings per share (EPS) for the quarter, FiscalAI reports. The business had revenue of $3.92 million for the quarter.

CapsoVision Stock Performance

CapsoVision stock traded down $0.74 during trading hours on Thursday, hitting $7.53. The company had a trading volume of 341,075 shares, compared to its average volume of 448,076. The firm has a market cap of $352.71 million and a P/E ratio of -3.44. The company has a 50-day moving average price of $5.52 and a two-hundred day moving average price of $6.21. CapsoVision has a 1 year low of $3.43 and a 1 year high of $15.37.

Analysts Set New Price Targets

Several brokerages have recently weighed in on CV. Wall Street Zen upgraded CapsoVision to a “hold” rating in a report on Saturday, January 10th. Weiss Ratings reaffirmed a “sell (e)” rating on shares of CapsoVision in a research report on Monday, December 29th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, CapsoVision has a consensus rating of “Moderate Buy” and an average price target of $6.00.

Institutional Trading of CapsoVision

Large investors have recently modified their holdings of the company. Deutsche Bank AG bought a new position in CapsoVision in the fourth quarter worth approximately $47,000. Wells Fargo & Company MN raised its position in CapsoVision by 66.4% during the 4th quarter. Wells Fargo & Company MN now owns 6,287 shares of the company’s stock valued at $67,000 after purchasing an additional 2,508 shares in the last quarter. New York State Common Retirement Fund purchased a new stake in shares of CapsoVision in the 3rd quarter worth $34,000. Virtu Financial LLC purchased a new stake in shares of CapsoVision in the 4th quarter worth $128,000. Finally, Millennium Management LLC purchased a new position in shares of CapsoVision during the fourth quarter valued at $163,000.

CapsoVision Company Profile

CapsoVision, Inc (NASDAQ: CV) is a medical device company specializing in advanced capsule endoscopy systems for gastrointestinal diagnostics. The company’s flagship product, the CapsoCam® Plus System, features a swallowable, tether-free capsule equipped with four side-viewing cameras that capture high-resolution, 360-degree images of the small intestine. By storing images internally rather than transmitting data wirelessly, CapsoCam Plus enables patients to maintain normal daily activities during the procedure and reduces the risk of signal loss or image drop-out.

In addition to its capsule hardware, CapsoVision offers CapsoCloud®, a secure, cloud-based platform that streamlines image retrieval, storage and reporting.